Ontology highlight
ABSTRACT: Background
Patients with hereditary hemorrhagic telangiectasia (HHT) are at risk for organ vascular malformations including arteriovenous malformations (AVMs) in the brain and lungs. North American HHT Centers of Excellence (CoEs) routinely screen for brain and lung AVMs, with the primary goal of detecting AVMs which can be treated before complications arise. Current international HHT guidelines provide recommendations for initial screening for brain and lung AVMs among children and adults with the disease, but rescreening recommendations are not comprehensively addressed and have not been reported. We determined current rescreening practices for brain and lung AVMs for children and adults with HHT among North American HHT CoEs.Methods
We surveyed North American HHT CoEs re
SUBMITTER: Beslow LA
PROVIDER: S-EPMC11549847 | biostudies-literature | 2024 Nov
REPOSITORIES: biostudies-literature